| Literature DB >> 31827785 |
Amlan K Patra1,2, Sebastian Geiger1, Katharina T Schrapers3, Hannah-Sophie Braun3, Heidrun Gehlen4, Alexander Starke5, Robert Pieper6, Adam Cieslak7, Malgorzata Szumacher-Strabel7, Jörg R Aschenbach1.
Abstract
BACKGROUND: The present study aimed at investigating the influence of 90% menthol-containing plant bioactive lipid compounds (PBLC, essential oils) on growth performance, blood haematological and biochemical profile, and nutrient absorption in sheep. Twenty-four growing Suffolk sheep were allotted into three dietary treatments: Control (without PBLC), lower dose of PBLC (PBLC-L; 80 mg/d) and higher dose of PBLC (PBLC-H; 160 mg/d). Sheep in all groups were fed meadow hay ad libitum plus 600 g/d of concentrate pellets for 28 d.Entities:
Keywords: Electrophysiology; Essential oil; Feed intake; Growth performance; Nutrient uptakes
Year: 2019 PMID: 31827785 PMCID: PMC6886202 DOI: 10.1186/s40104-019-0398-6
Source DB: PubMed Journal: J Anim Sci Biotechnol ISSN: 1674-9782
Ingredient and chemical composition of pelleted concentrates and hay fed to sheep
| Item | Concentratea | Hay | ||
|---|---|---|---|---|
| Control | PBLC-L | PBLC-H | ||
| Ingredient composition, g/kg as-fed | ||||
| Corn | 305 | 295 | 285 | |
| Barley | 305 | 305 | 305 | |
| Soybean meal | 348 | 348 | 348 | |
| Molasses | 30 | 30 | 30 | |
| Mineral and vitamin premixb | 5 | 5 | 5 | |
| Salt | 2 | 2 | 2 | |
| Limestone | 5 | 5 | 5 | |
| PBLC premixc | 0 | 10 | 20 | |
| Chemical composition | ||||
| Dry matter (DM), g/kg as-fed | 914 | 915 | 912 | 923 |
| Organic matter, g/kg DM | 949 | 950 | 948 | 958 |
| Crude protein, g/kg DM | 259 | 257 | 259 | 108 |
| Ether extract, g/kg DM | 30.8 | 25.1 | 25.8 | 9.60 |
| Neutral detergent fibre, g/kg DM | 125 | 140 | 152 | 641 |
| Acid detergent fibre, g/kg DM | 65.4 | 74.6 | 70.7 | 374 |
| Crude fibre, g/kg DM | 48.9 | 41.7 | 43.0 | 332 |
| Calcium, g/kg DM | 5.31 | 5.36 | 5.83 | 3.11 |
| Phosphorus, g/kg DM | 5.09 | 4.81 | 4.74 | 2.08 |
aControl: without PBLC; PBLC-L: lower dose (133.3 mg/kg) of PBLC; and PBLC-H: higher dose (266.7 mg/kg) of PBLC
bMineral and vitamin premix (Spezialfutter Neuruppin Ltd., Neuruppin, Germany), containing per kilogram dry matter: 160 g calcium, 40 g phosphorus, 100 g sodium, 30 g magnesium, 500,000 IU vitamin A, 50,000 IU vitamin D3, 500 mg vitamin E (as alpha-tocopherol acetate), 4500 mg zinc (as zinc oxide), 500 mg manganese (as Mn-(II)-oxide), 20 mg cobalt (as Co-(II)-carbonate), 20 mg iodine (as calcium iodate), and 35 mg selenium (as sodium selenite)
cPBLC premix (OAX17, PerformaNat GmbH, Berlin, Germany; containing 13.3 g PBLC/kg corn grains)
Chemical composition of mucosal and serosal buffers used in the Ussing chamber study
| Item | T&S solution | Mucosal solutions, rumen | Mucosal solutions, intestine | ||
|---|---|---|---|---|---|
| Na+-containing | Na+-free | Na+-containing | Na+-free | ||
| Composition, mmol/L | |||||
| CaCl2 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 |
| MgCl2 | 1.0 | 0 | 0 | 0 | 0 |
| HEPES, free acid | 10.0 | 10.0a | 10.0a | 10.0 | 10.0 |
| NaCl | 70.0 | 70.0 | 0.0 | 70.0 | 0.0 |
| HCl | 0.0 | 17.0 | 87.0 | 2.0 | 72.0 |
| Na-acetate | 0.0 | 25.0 | 0.0 | 0.0 | 0.0 |
| Acetic acid | 0.0 | 0.0 | 25.0 | 0.0 | 0.0 |
| Na-propionate | 0.0 | 10.0 | 0.0 | 0.0 | 0.0 |
| Propionic acid | 0.0 | 0.0 | 10.0 | 0.0 | 0.0 |
| Na-butyrate | 0.0 | 5.0 | 0.0 | 0.0 | 0.0 |
| Butyric acid | 0.0 | 0.0 | 5.0 | 0.0 | 0.0 |
| Na-gluconate | 40.0 | 0.0 | 0.0 | 40.0 | 0.0 |
| Gluconic acid | 0.0 | 0.0 | 0.0 | 0.0 | 40.0 |
| NMDG free base | 5.0 | 2.0 | 112 | 7.0 | 117 |
| KH2PO4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 |
| K2HPO4 | 2.4 | 2.4 | 2.4 | 2.4 | 2.4 |
| NaHCO3 | 25.0 | 25.0 | 0.0 | 25.0 | 0.0 |
| Cholin- HCO3 | 0.0 | 0.0 | 25.0 | 0.0 | 25.0 |
| Enrofloxacine | 0.0278 | 0.0278 | 0.0278 | 0.0278 | 0.0278 |
| Mannitol | 0 | 19.0 | 19.0 | 9.0 | 9.0 |
| Glucose | 10.0 | 0 | 0 | 0 | 0 |
| Osmolarity, mOsmol/L | 288 | 288 | 288 | 288 | 288 |
| pH | 7.4 | 6.4 | 6.4 | 7.4 | 7.4 |
HEPES: 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid; NMDG: N-methyl-D-glucamine; T&S: Transport and serosal
aRuminal mucosal buffer contained MES (2-morpholinoethanesulfonic acid) free acid instead of HEPES free acid
Effect of two doses of dietary menthol-rich plant bioactive lipid compounds (PBLC) on daily body weight (BW) gain and daily nutrient dry matter intake in sheep
| Attribute | Treatmenta,b | SEM | Contrastc | ||||
|---|---|---|---|---|---|---|---|
| Control | PBLC-L | PBLC-H | 1 | 2 | 3 | ||
| Initial BW, kgc | 35.5 | 34.3 | 35.9 | 0.83 | 0.69 | 0.18 | 0.71 |
| Final BW, kg | 39.1 | 38.4 | 39.7 | 0.63 | 0.47 | 0.43 | 0.84 |
| Average daily BW gain, g/dd | 170 | 195 | 180 | 12.8 | 0.61 | 0.32 | 0.34 |
| Hay intake, g/d | 660 | 707# | 725# | 25.6 | 0.090 | 0.65 | 0.091 |
| Hay intake, g/(d · kg BW) | 17.6 | 19.1# | 19.0# | 0.55 | 0.091 | 0.25 | 0.047 |
| Total feed intake, g/d | 1209 | 1255# | 1272# | 25.0 | 0.094 | 0.64 | 0.093 |
| Total feed intake, g/(d · kg BW) | 32.4 | 34.1# | 33.4# | 0.51 | 0.17 | 0.073 | 0.041 |
| Crude protein intake, g/d | 213 | 215# | 225* | 3.58 | 0.022 | 0.40 | 0.096 |
| NDF intake, g/d | 532 | 552 | 578 | 19.5 | 0.12 | 0.77 | 0.13 |
NDF: neutral detergent fibre; SEM: standard error of mean
aControl: without PBLC; PBLC-L: lower dose (80 mg/d) of PBLC; and PBLC-H: higher dose (160 mg/d) of PBLC
bOne outlier for average daily gain (g/d) < 97, hay intake (g/d) < 525, total feed intake (g/d) < 1126, and hay intake (g/kg BW) < 15.3 was removed for PBLC-L (n = 7) before statistical analyses
cContrast: 1 = linear effect; 2 = quadratic effect; and 3 = Control versus both PBLC groups
dAverage daily gain and the initial BW to calculate this gain are based on the last 21 d of the study to nullify the effect of rumen fill during the first week that might have occurred due to changes in feed intake by PBLC
#/*Mean values differ compared with the control at P < 0.10/0.05
Effect of two doses of dietary menthol-rich PBLC on different haematological values in sheep
| Attribute | Treatmenta,b | SEM | Contrastc | ||||
|---|---|---|---|---|---|---|---|
| Control | PBLC-L | PBLC-H | 1 | 2 | 3 | ||
| Leucocyte profile | |||||||
| Total leucocytes, ×109/L | 15.2 | 13.4 | 14.1 | 0.72 | 0.34 | 0.19 | 0.12 |
| Lymphocyte, ×109/L | 12.0 | 10.9 | 12.0 | 0.060 | 0.95 | 0.16 | 0.41 |
| Lymphocyte, % | 79.7 | 85.0** | 83.0* | 1.09 | 0.044 | 0.020 | 0.006 |
| Monocyte, ×109/L | 0.074 | 0.068 | 0.072 | 0.0038 | 0.65 | 0.29 | 0.34 |
| Monocyte, % | 0.48 | 0.51 | 0.51 | 0.026 | 0.38 | 0.78 | 0.39 |
| Neutrophil, ×109/L | 2.96 | 2.26# | 2.18* | 0.277 | 0.055 | 0.34 | 0.031 |
| Neutrophil, % | 19.8 | 14.4** | 16.5* | 1.08 | 0.042 | 0.019 | 0.005 |
| Erythrocyte profile | |||||||
| Total erythrocytes, × 106/L | 15.0 | 14.6 | 14.7 | 0.46 | 0.66 | 0.65 | 0.54 |
| Haemoglobin, g/dL | 12.5 | 12.2 | 12.5 | 0.38 | 0.94 | 0.53 | 0.70 |
| PCV, % | 43.7 | 44.4 | 44.3 | 1.41 | 0.76 | 0.80 | 0.69 |
| MCV, fL | 23.1 | 23.9 | 23.4 | 0.64 | 0.79 | 0.44 | 0.53 |
| MCH, pg | 8.30 | 8.36 | 8.40 | 0.23 | 0.76 | 0.96 | 0.78 |
| MCHC, g/dL | 35.8 | 35.2 | 36.0 | 0.70 | 0.89 | 0.42 | 0.70 |
| RDWc, % | 28.4 | 28.3 | 28.8 | 0.70 | 0.67 | 0.72 | 0.85 |
| RDWs, fL | 24.7 | 25.0 | 25.1 | 0.62 | 0.66 | 0.90 | 0.66 |
| Platelet profile | |||||||
| Platelets, ×106/L | 368 | 372 | 389 | 61.3 | 0.81 | 0.93 | 0.87 |
| MPV, fL | 5.15 | 5.08 | 5.14 | 0.11 | 0.94 | 0.62 | 0.75 |
| PCT, % | 0.19 | 0.19 | 0.20 | 0.031 | 0.84 | 0.81 | 0.96 |
| PDWc, % | 21.6 | 21.2 | 21.7 | 0.55 | 0.95 | 0.52 | 0.79 |
| PDWs, fL | 3.84 | 3.70 | 3.80 | 0.16 | 0.87 | 0.55 | 0.66 |
PCV packed cell volume, MCV mean corpuscular volume, MCH mean corpuscular haemoglobin, MCHC mean corpuscular haemoglobin concentration, RDWc red cell distribution width (co-efficient of variations), RDWs red cell distribution width (standard deviation), MPV mean platelet volume, PCT plateletcrit, PDWc platelet distribution width (co-efficient of variations); and PDWs: platelet distribution width (standard deviation)
aControl: without PBLC; PBLC-L: lower dose (133.3 mg/kg) of PBLC; and PBLC-H: higher dose (266.7 mg/kg) of PBLC
bOne outlier for lymphocyte (%) < 70 in PBLC-L (n = 7) and neutrophil (%) > 29 in PBLC-L (n = 7) and leucocyte number > 22.9 × 109/L in PBLC-H (n = 7) was removed before analysis
cContrast: 1 = linear effect; 2 = quadratic effect; and 3 = Control versus both PBLC groups
#/*/**Mean values differ compared with the control at P < 0.10/0.05/0.01
Effect of two doses of dietary menthol-rich PBLC on selected serum metabolites in sheep
| Attribute | Treatmenta | SEM | Contrastb | ||||
|---|---|---|---|---|---|---|---|
| Control | PBLC-L | PBLC-H | 1 | 2 | 3 | ||
| Glucose, mmol/L | 4.04 | 3.95 | 3.98 | 0.065 | 0.49 | 0.43 | 0.32 |
| Calcium, mmol/L | 2.62 | 2.62 | 2.68# | 0.022 | 0.089 | 0.41 | 0.26 |
| Bilirubin, μmol/L | 0.76 | 0.86 | 0.81 | 0.107 | 0.74 | 0.57 | 0.57 |
| Tryglyceride, mmol/L | 0.23 | 0.22 | 0.24 | 0.022 | 0.81 | 0.63 | 0.98 |
| Cholesterol, mmol/L | 1.60 | 1.65 | 1.64 | 0.044 | 0.53 | 0.44 | 0.41 |
| Magnesium, mmol/L | 1.00 | 1.01 | 1.01 | 0.018 | 0.90 | 0.99 | 0.91 |
| Urea, mmol/L | 9.38 | 10.1 | 9.61 | 0.382 | 0.67 | 0.21 | 0.32 |
SEM standard error of mean
aControl: without PBLC; PBLC-L: lower dose (80 mg/d) of PBLC; and PBLC-H: higher dose (160 mg/d) of PBLC
bContrast: 1 = linear effect; 2 = quadratic effect; and 3 = Control versus both PBLC groups
#Mean values differ compared with the control at P < 0.10
The effect of menthol-rich PBLC on concentrations (μmol/L) of free amino acids in serum of sheep
| Item | Treatmenta | SEM | Contrastb | ||||
|---|---|---|---|---|---|---|---|
| Control | PBLC-L | PBLC-H | 1 | 2 | 3 | ||
| Ala | 60 | 61 | 61 | 0.6 | 0.30 | 0.45 | 0.20 |
| Val | 118 | 120 | 118 | 2.4 | 0.96 | 0.50 | 0.70 |
| Leu | 133 | 137 | 137 | 1.8 | 0.14 | 0.49 | 0.11 |
| Ile | 133 | 136 | 136 | 1.3 | 0.19 | 0.46 | 0.14 |
| Phe | 223 | 227 | 228 | 2.5 | 0.17 | 0.63 | 0.15 |
| Met | 154 | 154 | 154 | 0.6 | 0.75 | 0.92 | 0.82 |
| Proc | 103 | 105# | 105 | 1.0 | 0.12 | 0.32 | 0.072 |
| Glyc | 60 | 66# | 59 | 2.5 | 0.85 | 0.058 | 0.41 |
| Ser | 82 | 82 | 84 | 1.7 | 0.42 | 0.72 | 0.60 |
| Cys | 200 | 200 | 201 | 0.7 | 0.13 | 0.39 | 0.37 |
| Thr | 113 | 115 | 115 | 1.2 | 0.30 | 0.50 | 0.22 |
| Tyr | 289 | 298 | 290 | 4.3 | 0.84 | 0.11 | 0.32 |
| Asp+Asnc | 121 | 125# | 128* | 1.4 | 0.005 | 0.79 | 0.009 |
| Glu + Glnc | 160 | 174* | 174* | 4.5 | 0.041 | 0.22 | 0.020 |
| Lysc | 147 | 148 | 152* | 1.5 | 0.054 | 0.50 | 0.17 |
| His | 171 | 171 | 168 | 1.9 | 0.31 | 0.62 | 0.52 |
| Arg | 345 | 353 | 341 | 11.9 | 0.81 | 0.41 | 0.83 |
| Total | 2611 | 2672 | 2651 | 32.0 | 0.42 | 0.52 | 0.68 |
SEM standard error of mean
aControl: without PBLC; PBLC-L: lower dose (80 mg/d) of PBLC; and PBLC-H: higher dose (160 mg/d) of PBLC
bContrast: 1 = linear effect; 2 = quadratic effect; and 3 = Control versus both PBLC groups
cSince CP intake could be a factor affecting serum amino acid concentrations, CP intake was used as covariate for amino acids those resulted in P < 0.10, and the statistical results are provided in the text
#/*Mean values differ compared with the control at P < 0.10/0.05
Effect of two doses of dietary menthol-rich PBLC on ruminal and jejunal short-circuit current [Isc; μEq/(cm2 · h)], conductance (Gt; mS/cm2) and uptakes [pmol/(cm2 · min)] of glucose (Ugluc) and methionine (Umet) in the presence (+ Na+) or absence of Na+ (− Na+)
| Attribute | Treatmenta,b | SEM | Contrastc | ||||
|---|---|---|---|---|---|---|---|
| Control | PBLC-L | PBLC-H | 1 | 2 | 3 | ||
| Rumen | |||||||
| | 10.8 | 21.8** | 20.6** | 1.46 | < 0.001 | 0.004 | < 0.001 |
| | 3.38 | 3.62* | 4.40** | 0.26 | 0.013 | 0.41 | 0.065 |
| | 237 | 251 | 274 | 36.6 | 0.48 | 0.92 | 0.57 |
| | 203 | 194 | 255* | 17.5 | 0.053 | 0.12 | 0.33 |
| | 56.2 | 60.8 | 71.2 | 11.3 | 0.36 | 0.84 | 0.49 |
| | 50.3 | 45.7 | 67.9* | 5.48 | 0.036 | 0.061 | 0.35 |
| Jejunum | |||||||
| | 5.27 | 9.40 | 9.91# | 1.81 | 0.085 | 0.43 | 0.063 |
| | 28.9 | 26.6 | 27.7 | 1.96 | 0.66 | 0.49 | 0.47 |
| | 1239 | 1465 | 1145 | 151 | 0.66 | 0.16 | 0.73 |
| | 842 | 893 | 746 | 127 | 0.60 | 0.53 | 0.89 |
| | 715 | 817 | 603 | 94.0 | 0.40 | 0.18 | 0.97 |
| | 376 | 463 | 365 | 55.3 | 0.89 | 0.19 | 0.59 |
SEM standard error of mean
aControl: without PBLC; PBLC-L: lower dose (80 mg/d) of PBLC; and PBLC-H: higher dose (160 mg/d) of PBLC
bOne animal in each treatment was removed due to high conductivity
cContrast: 1 = linear effect; 2 = quadratic effect; and 3 = Control versus both PBLC groups
#/*/**Mean values differ compared with the control at P < 0.10/0.05/0.01
Fig. 1Correlations between serum glucose concentrations and ruminal glucose uptakes (a) or intestinal glucose uptakes (b) in the presence of Na+ in sheep. Control: without PBLC; PBLC-L: lower dose (80 mg/d) of PBLC; and PBLC-H: higher dose (160 mg/d) of PBLC